263 related articles for article (PubMed ID: 11156851)
21. Pitavastatin inhibits intimal hyperplasia in rabbit vein graft.
Fujita H; Banno H; Yamanouchi D; Kobayashi M; Yamamoto K; Komori K
J Surg Res; 2008 Aug; 148(2):238-43. PubMed ID: 18395752
[TBL] [Abstract][Full Text] [Related]
22. Ramipril and experimental vein graft intimal hyperplasia.
Davies MG; Klyachkin ML; Barber L; Svendsen E; Hagen PO
Angiology; 1995 Feb; 46(2):91-7. PubMed ID: 7702205
[TBL] [Abstract][Full Text] [Related]
23. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
[TBL] [Abstract][Full Text] [Related]
24. The temporal sequence of G-protein expression in intimal hyperplasia.
Davies MG; Barber L; Dhanraj DN; Gettys TW; Ramkumar V; Hagen PO
J Surg Res; 1996 Jun; 63(1):115-22. PubMed ID: 8661183
[TBL] [Abstract][Full Text] [Related]
25. Perivenous application of cyanoacrylate tissue sealants reduces intimal and medial thickening of the vein graft and inflammatory responses in a rabbit model of carotid artery bypass grafting.
Dai L; Gao M; Gu C; Zhang F; Yu Y
Eur J Cardiothorac Surg; 2016 Feb; 49(2):675-81. PubMed ID: 25838460
[TBL] [Abstract][Full Text] [Related]
26. The effect of low molecular weight heparin on intimal hyperplasia in vein grafts.
Wilson NV; Salisbury JR; Kakkar VV
Eur J Vasc Surg; 1994 Jan; 8(1):60-4. PubMed ID: 8307218
[TBL] [Abstract][Full Text] [Related]
27. Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts.
Annex BH; Davies MG; Fulton GJ; Huynh TT; Channon KM; Ezekowitz MD; Hagen PO
J Surg Res; 1998 Dec; 80(2):164-70. PubMed ID: 9878308
[TBL] [Abstract][Full Text] [Related]
28. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.
Ohnaka M; Marui A; Yamahara K; Minakata K; Yamazaki K; Kumagai M; Masumoto H; Tanaka S; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):676-82.e2. PubMed ID: 24507892
[TBL] [Abstract][Full Text] [Related]
29. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
Gulkarov I; Bohmann K; Cinnante KM; Pirelli L; Yu PJ; Grau JB; Pintucci G; Galloway AC; Mignatti P
J Surg Res; 2009 Jun; 154(1):150-6. PubMed ID: 18805551
[TBL] [Abstract][Full Text] [Related]
30. Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts.
Zhang WD; Bai HZ; Sawa Y; Yamakawa T; Kadoba K; Taniguchi K; Masuda J; Ogata J; Shirakura R; Matsuda H
J Vasc Surg; 1999 Jul; 30(1):169-83. PubMed ID: 10394167
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.
Guzik TJ; Mussa S; Gastaldi D; Sadowski J; Ratnatunga C; Pillai R; Channon KM
Circulation; 2002 Apr; 105(14):1656-62. PubMed ID: 11940543
[TBL] [Abstract][Full Text] [Related]
32. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
[TBL] [Abstract][Full Text] [Related]
33. Alterations in collagen subtype III and IV protein in experimental venous bypass grafting.
Fulton GJ; Channon KM; Davies MG; Annex BH; Hagen PO
Coron Artery Dis; 1998; 9(4):191-7. PubMed ID: 9649925
[TBL] [Abstract][Full Text] [Related]
34. Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: a limited biological effect as a result of the loss of medial smooth muscle cells.
Ohta S; Komori K; Yonemitsu Y; Onohara T; Matsumoto T; Sugimachi K
Surgery; 2002 Jun; 131(6):644-53. PubMed ID: 12075177
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
Davies MG; Fulton GJ; Barber L; Dalen H; Svendsen E; Hagen PO
Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):151-61. PubMed ID: 8760976
[TBL] [Abstract][Full Text] [Related]
36. Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts.
Kissin M; Kansal N; Pappas PJ; DeFouw DO; Durán WN; Hobson RW
J Vasc Surg; 2000 Jan; 31(1 Pt 1):69-83. PubMed ID: 10642710
[TBL] [Abstract][Full Text] [Related]
37. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts.
Huynh TT; Davies MG; Trovato MJ; Barber L; Safi HJ; Hagen PO
J Surg Res; 1999 Jun; 84(2):223-32. PubMed ID: 10357924
[TBL] [Abstract][Full Text] [Related]
38. Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft.
Handa M; Li W; Morioka K; Takamori A; Yamada N; Ihaya A
J Vasc Surg; 2008 Dec; 48(6):1566-74. PubMed ID: 18848756
[TBL] [Abstract][Full Text] [Related]
39. Increased intimal hyperplasia in experimental vein graft stenting compared to arterial stenting: comparisons in a new rabbit model of stent injury.
Alp NJ; West NE; Arnold N; Gunn J; Banning AP; Channon KM
Cardiovasc Res; 2002 Oct; 56(1):164-72. PubMed ID: 12237177
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production.
West NE; Qian H; Guzik TJ; Black E; Cai S; George SE; Channon KM
Circulation; 2001 Sep; 104(13):1526-32. PubMed ID: 11571247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
